| Dr Mathew George Mathai, MD | |
|
5900 S. Lake Dr., Cudahy, WI 53110 | |
| (414) 744-4000 | |
| (414) 489-4022 |
| Full Name | Dr Mathew George Mathai |
|---|---|
| Gender | Male |
| Speciality | Pulmonary Disease |
| Experience | 28 Years |
| Location | 5900 S. Lake Dr., Cudahy, Wisconsin |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1104854363 | NPI | - | NPPES |
| 34650600 | Medicaid | WI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RP1001X | Internal Medicine - Pulmonary Disease | 45983 (Wisconsin) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Watertown Memorial Hospital | Watertown, WI | Hospital |
| Ascension Se Wisconsin Hospital - St Joseph Campus | Milwaukee, WI | Hospital |
| Aurora St Lukes Medical Center | Milwaukee, WI | Hospital |
| Ascension St Francis Hospital | Milwaukee, WI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Pulmonary And Critical Care Associates, Sc | 4183695737 | 7 |
| Watertown Physician Practices Llc | 8022329408 | 53 |
| Wheaton Franciscan Medical Group Inc | 8628980943 | 594 |
News Archive
Eli Lilly and Company announced today that patients with moderate-to-severe plaque psoriasis who did not respond to treatment with etanercept achieved significant improvement in their psoriasis plaques when treated with ixekizumab in a Phase 3 clinical trial. Detailed results of the UNCOVER-2 study were presented during the American Academy of Dermatology Annual Meeting taking place March 4-8 in Washington, D.C.
Researchers at the University of Michigan looked at how much protection additional birth weight added against developing the disease years later. They found that every 1.1 pounds of birth weight decreases the risk of developing tuberculosis later by 46 percent among identical twins.
Anti-abortion activists in Republican-dominated states have succeeded in pushing various bills that limit the procedure.
Dr. Judd Shellito, Chief of the Section of Pulmonary and Critical Care Medicine at LSU Health Sciences Center New Orleans, has been awarded approximately $9 million in grant funding to develop a vaccine against Pneumocystis, an important cause of pneumonia in people with HIV infection. This potentially fatal illness is the most common serious opportunistic infection in people with HIV.
In findings they call counterintuitive, a team of UCLA-led researchers suggests that blocking a protein, which is crucial to initiating the immune response against viral infections, may actually help combat HIV.
› Verified 6 days ago
| Entity Name | Ascension Medical Group-southeast Wisconsin Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1609881077 PECOS PAC ID: 8628980943 Enrollment ID: O20031104000421 |
News Archive
Eli Lilly and Company announced today that patients with moderate-to-severe plaque psoriasis who did not respond to treatment with etanercept achieved significant improvement in their psoriasis plaques when treated with ixekizumab in a Phase 3 clinical trial. Detailed results of the UNCOVER-2 study were presented during the American Academy of Dermatology Annual Meeting taking place March 4-8 in Washington, D.C.
Researchers at the University of Michigan looked at how much protection additional birth weight added against developing the disease years later. They found that every 1.1 pounds of birth weight decreases the risk of developing tuberculosis later by 46 percent among identical twins.
Anti-abortion activists in Republican-dominated states have succeeded in pushing various bills that limit the procedure.
Dr. Judd Shellito, Chief of the Section of Pulmonary and Critical Care Medicine at LSU Health Sciences Center New Orleans, has been awarded approximately $9 million in grant funding to develop a vaccine against Pneumocystis, an important cause of pneumonia in people with HIV infection. This potentially fatal illness is the most common serious opportunistic infection in people with HIV.
In findings they call counterintuitive, a team of UCLA-led researchers suggests that blocking a protein, which is crucial to initiating the immune response against viral infections, may actually help combat HIV.
› Verified 6 days ago
| Entity Name | Aurora Medical Group, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1427271378 PECOS PAC ID: 6709794258 Enrollment ID: O20031105000725 |
News Archive
Eli Lilly and Company announced today that patients with moderate-to-severe plaque psoriasis who did not respond to treatment with etanercept achieved significant improvement in their psoriasis plaques when treated with ixekizumab in a Phase 3 clinical trial. Detailed results of the UNCOVER-2 study were presented during the American Academy of Dermatology Annual Meeting taking place March 4-8 in Washington, D.C.
Researchers at the University of Michigan looked at how much protection additional birth weight added against developing the disease years later. They found that every 1.1 pounds of birth weight decreases the risk of developing tuberculosis later by 46 percent among identical twins.
Anti-abortion activists in Republican-dominated states have succeeded in pushing various bills that limit the procedure.
Dr. Judd Shellito, Chief of the Section of Pulmonary and Critical Care Medicine at LSU Health Sciences Center New Orleans, has been awarded approximately $9 million in grant funding to develop a vaccine against Pneumocystis, an important cause of pneumonia in people with HIV infection. This potentially fatal illness is the most common serious opportunistic infection in people with HIV.
In findings they call counterintuitive, a team of UCLA-led researchers suggests that blocking a protein, which is crucial to initiating the immune response against viral infections, may actually help combat HIV.
› Verified 6 days ago
| Entity Name | Pulmonary And Critical Care Associates, Sc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1104938331 PECOS PAC ID: 4183695737 Enrollment ID: O20040805000598 |
News Archive
Eli Lilly and Company announced today that patients with moderate-to-severe plaque psoriasis who did not respond to treatment with etanercept achieved significant improvement in their psoriasis plaques when treated with ixekizumab in a Phase 3 clinical trial. Detailed results of the UNCOVER-2 study were presented during the American Academy of Dermatology Annual Meeting taking place March 4-8 in Washington, D.C.
Researchers at the University of Michigan looked at how much protection additional birth weight added against developing the disease years later. They found that every 1.1 pounds of birth weight decreases the risk of developing tuberculosis later by 46 percent among identical twins.
Anti-abortion activists in Republican-dominated states have succeeded in pushing various bills that limit the procedure.
Dr. Judd Shellito, Chief of the Section of Pulmonary and Critical Care Medicine at LSU Health Sciences Center New Orleans, has been awarded approximately $9 million in grant funding to develop a vaccine against Pneumocystis, an important cause of pneumonia in people with HIV infection. This potentially fatal illness is the most common serious opportunistic infection in people with HIV.
In findings they call counterintuitive, a team of UCLA-led researchers suggests that blocking a protein, which is crucial to initiating the immune response against viral infections, may actually help combat HIV.
› Verified 6 days ago
| Entity Name | Watertown Physician Practices Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1770964363 PECOS PAC ID: 8022329408 Enrollment ID: O20150626000114 |
News Archive
Eli Lilly and Company announced today that patients with moderate-to-severe plaque psoriasis who did not respond to treatment with etanercept achieved significant improvement in their psoriasis plaques when treated with ixekizumab in a Phase 3 clinical trial. Detailed results of the UNCOVER-2 study were presented during the American Academy of Dermatology Annual Meeting taking place March 4-8 in Washington, D.C.
Researchers at the University of Michigan looked at how much protection additional birth weight added against developing the disease years later. They found that every 1.1 pounds of birth weight decreases the risk of developing tuberculosis later by 46 percent among identical twins.
Anti-abortion activists in Republican-dominated states have succeeded in pushing various bills that limit the procedure.
Dr. Judd Shellito, Chief of the Section of Pulmonary and Critical Care Medicine at LSU Health Sciences Center New Orleans, has been awarded approximately $9 million in grant funding to develop a vaccine against Pneumocystis, an important cause of pneumonia in people with HIV infection. This potentially fatal illness is the most common serious opportunistic infection in people with HIV.
In findings they call counterintuitive, a team of UCLA-led researchers suggests that blocking a protein, which is crucial to initiating the immune response against viral infections, may actually help combat HIV.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Mathew George Mathai, MD 5900 S. Lake Dr., Cudahy, WI 53110 Ph: (414) 744-4000 | Dr Mathew George Mathai, MD 5900 S. Lake Dr., Cudahy, WI 53110 Ph: (414) 744-4000 |
News Archive
Eli Lilly and Company announced today that patients with moderate-to-severe plaque psoriasis who did not respond to treatment with etanercept achieved significant improvement in their psoriasis plaques when treated with ixekizumab in a Phase 3 clinical trial. Detailed results of the UNCOVER-2 study were presented during the American Academy of Dermatology Annual Meeting taking place March 4-8 in Washington, D.C.
Researchers at the University of Michigan looked at how much protection additional birth weight added against developing the disease years later. They found that every 1.1 pounds of birth weight decreases the risk of developing tuberculosis later by 46 percent among identical twins.
Anti-abortion activists in Republican-dominated states have succeeded in pushing various bills that limit the procedure.
Dr. Judd Shellito, Chief of the Section of Pulmonary and Critical Care Medicine at LSU Health Sciences Center New Orleans, has been awarded approximately $9 million in grant funding to develop a vaccine against Pneumocystis, an important cause of pneumonia in people with HIV infection. This potentially fatal illness is the most common serious opportunistic infection in people with HIV.
In findings they call counterintuitive, a team of UCLA-led researchers suggests that blocking a protein, which is crucial to initiating the immune response against viral infections, may actually help combat HIV.
› Verified 6 days ago
Dr. Manila Sodhi, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 5900 S Lake Dr, 2 West, Cudahy, WI 53110 Phone: 414-489-4190 Fax: 414-489-4015 | |
Dr. Arturo Eduardo Eyzaguirre, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 5900 S Lake Dr, Cudahy, WI 53110 Phone: 414-744-4000 Fax: 414-489-4022 | |
Alyssa Kaleta, DO Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 5900 S Lake Dr, Cudahy, WI 53110 Phone: 414-489-4051 | |
Anna M Lamnari, MD Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 3533 E Ramsey Avenue, Cudahy, WI 53110 Phone: 414-769-6600 Fax: 414-486-2297 | |
Dr. Paul Aldo Lisi, D.O. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 5900 S Lake Dr, Pulmonary And Critical Care, Cudahy, WI 53110 Phone: 414-489-4260 Fax: 414-489-4022 | |
Dr. Jared A Ludlow, MD Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 5900 S Lake Dr, Cudahy, WI 53110 Phone: 414-489-9000 |